Suminami Y, Kishi F, Sekiguchi K, Kato H (1992). "Squamous cell carcinoma antigen is a new member of the serine protease inhibitors". Biochem. Biophys. Res. Commun. 181 (1): 51–8. doi:10.1016/S0006-291X(05)81380-4. PMID1958219.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Schick C, Pemberton PA, Shi GP, et al. (1998). "Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis". Biochemistry. 37 (15): 5258–66. doi:10.1021/bi972521d. PMID9548757.
Cataltepe S, Gornstein ER, Schick C, et al. (2000). "Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas". J. Histochem. Cytochem. 48 (1): 113–22. doi:10.1177/002215540004800112. PMID10653592.
Hamada K, Shinomiya H, Asano Y, et al. (2001). "Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter". Biochim. Biophys. Acta. 1518 (1–2): 124–31. doi:10.1016/s0167-4781(01)00174-9. PMID11267667.
Shimada H, Nabeya Y, Okazumi S, et al. (2003). "Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma". Surgery. 133 (5): 486–94. doi:10.1067/msy.2003.139. PMID12773976.
Micke O, Bruns F, Schäfer U, et al. (2003). "The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck". Anticancer Res. 23 (2A): 907–11. PMID12820321.
Nawata S, Nakamura K, Hirakawa H, et al. (2004). "Electrophoretic analysis of the cleaved form of serpin, squamous cell carcinoma antigen-1 in normal and malignant squamous epithelial tissues". Electrophoresis. 24 (14): 2277–82. doi:10.1002/elps.200305501. PMID12874860.
Masumoto K, Sakata Y, Arima K, et al. (2003). "Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1". J. Biol. Chem. 278 (46): 45296–304. doi:10.1074/jbc.M307741200. PMID12949073.
Moore PL, Ong S, Harrison TJ (2004). "Squamous cell carcinoma antigen 1-mediated binding of hepatitis B virus to hepatocytes does not involve the hepatic serpin clearance system". J. Biol. Chem. 278 (47): 46709–17. doi:10.1074/jbc.M302842200. PMID12975381.
Onishi A, Nakashiro K, Mihara M, et al. (2004). "Basic and clinical studies on quantitative analysis of lymph node micrometastasis in oral cancer". Oncol. Rep. 11 (1): 33–9. doi:10.3892/or.11.1.33. PMID14654899.
Hirakawa H, Nawata S, Sueoka K, et al. (2004). "Regulation of squamous cell carcinoma antigen production by E-cadherin mediated cell-cell adhesion in squamous cell carcinoma cell line". Oncol. Rep. 11 (2): 415–9. doi:10.3892/or.11.2.415. PMID14719077.
Ruvoletto MG, Tono N, Carollo D, et al. (2004). "Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus". J. Gen. Virol. 85 (Pt 3): 621–4. doi:10.1099/vir.0.19130-0. PMID14993646.